Bio-Techne
TECH
#1486
Rank
S$15.75 B
Marketcap
$99.15
Share price
2.49%
Change (1 day)
-3.82%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Revenue for Bio-Techne (TECH)

Revenue in 2024 (TTM): S$1.55 Billion

According to Bio-Techne's latest financial reports the company's current revenue (TTM ) is S$1.58 Billion. In 2023 the company made a revenue of S$1.51 Billion an increase over the revenue in the year 2022 that were of S$1.50 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bio-Techne from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) S$1.55 B2.85%
2023 S$1.51 B0.73%
2022 S$1.50 B7.86%
2021 S$1.39 B31.69%
2020 S$1.05 B5.28%
2019 S$1.00 B7.8%
2018 S$0.93 B16.17%
2017 S$0.80 B4.88%
2016 S$0.76 B16.18%
2015 S$0.65 B21.89%
2014 S$0.53 B29.04%
2013 S$0.41 B9.49%
2012 S$0.38 B-3.77%
2011 S$0.39 B13.05%
2010 S$0.35 B-5.53%
2009 S$0.37 B-3.18%
2008 S$0.38 B11.76%
2007 S$0.34 B5.82%
2006 S$0.32 B1.98%
2005 S$0.31 B16.05%
2004 S$0.27 B5.25%
2003 S$0.26 B9.04%
2002 S$0.23 B5.91%
2001 S$0.22 B20.03%
2000 S$0.18 B15.46%
1999 S$0.16 B24.72%
1998 S$0.13 B21.98%
1997 S$0.10 B32.58%
1996 S$80.75 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
S$57.41 B 3,516.47%๐Ÿ‡บ๐Ÿ‡ธ USA
S$3.49 B 120.23%๐Ÿ‡บ๐Ÿ‡ธ USA
S$27.34 B 1,622.29%๐Ÿ‡บ๐Ÿ‡ธ USA
S$27.14 B 1,609.65%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.66 B 67.82%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
S$73.73 B 4,544.23%๐Ÿ‡บ๐Ÿ‡ธ USA
S$43.23 M-97.28%๐Ÿ‡บ๐Ÿ‡ธ USA